Xencor (XNCR) EBT Margin (2013 - 2026)

Xencor's (XNCR) quarterly EBT Margin came in at 2848.45% in Q1 2026, down 270099.0% year-on-year from N/an in Q1 2025, and down 18754.12% on a QoQ basis from 15.11% in Q4 2025.

Xencor (XNCR) EBT Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of EBT Margin data on file, last reported at 2848.45% in Q1 2026.

  • On a quarterly basis, EBT Margin fell 270099.0% year-over-year to 2848.45% in Q1 2026; TTM through Mar 2026 was 174.61%, a 1029.0% decrease from a year earlier, with the FY2025 full-year figure at 71.38%, up 14124.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 2848.45%, down from 15.11% in the prior quarter.
  • Over the last five years, EBT Margin for XNCR reached as high as 30.16% in Q1 2022 and fell as low as 2848.45% in Q1 2026.
  • Historically, EBT Margin has averaged 299.26% across 5 years, with a median of 116.02% in 2022.
  • Across the five-year window, EBT Margin soared 31586 bps in 2025 and sank 270099 bps in 2026, its largest moves.
  • Year by year, EBT Margin stood at 57.64% in 2022, then jumped by 57 bps to 24.79% in 2023, then sank by 241 bps to 84.45% in 2024, then jumped by 82 bps to 15.11% in 2025, then tumbled by 18754 bps to 2848.45% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 2848.45% in Q1 2026, 15.11% in Q4 2025, and 28.7% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Xencor 1.47 Bn 1.09 Bn - -2,848.45%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,848.45%
Dec 31, 2025 -15.11%
Sep 30, 2025 -28.70%
Jun 30, 2025 -71.26%
Mar 31, 2025 -147.46%
Dec 31, 2024 -84.45%
Sep 30, 2024 -266.59%
Jun 30, 2024 -287.71%
Mar 31, 2024 -463.31%
Dec 31, 2023 -24.79%
Sep 30, 2023 -40.99%
Jun 30, 2023 -156.28%
Mar 31, 2023 -308.26%
Dec 31, 2022 -57.64%
Sep 30, 2022 -116.02%
Jun 30, 2022 -200.62%
Mar 31, 2022 30.16%
Dec 31, 2021 47.44%
Sep 30, 2021 -204.19%
Jun 30, 2021 -83.47%